Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...
IBEX stock earns a Strong Buy rating with a $30.66 target. Find out its AI-driven growth, high client retention, and Q2 FY25 ...
With the targets of the Vision 2026 plan interrupted by the pandemic and changes in China consumer appetite, leading to weak 2024 earnings, Kose has revamped its focus. The key components of its ...
SK Telecom retains a fairly strong balance sheet, with net debt around 1.7 times EBITDA at end-2024. We see this as within the normal range of 1 to 2 times for telecom service companies and we expect ...
Apple, which has launched Apple Intelligence in the US market to offer integrated ChatGPT services, is expected to launch ...
Investment firms, including TPG Growth and GIC-backed entities, seek CCI approval for healthcare sector restructuring and ...
Epic Concesiones 2 Private Limited and Infrastructure Yield Plus seek CCI approval for significant road infrastructure ...
Q4 sales & FY 2024 resultsSales & Ebita margin in line with revised guidance 2024; FCF conversion exceeding objective Positive North ...